Andrew Perlman

Andrew J.
Perlman is the founder of Innate Immune, Inc., founded in 2004, serving as Chief Executive Officer & Director.
Dr. Perlman is the founder of Velocity Pharmaceutical Development LLC, founded in 2011, serving as Chief Medical Officer & Managing Director.
Current jobs include CEO, Chief Financial Officer & Secretary at Spitfire Pharma, Inc.; Independent Director at Arcus Biosciences, Inc. since 2020; Managing Director & Head-Non-Clinical Development at X-37 Service Co., Inc.; and Advisor at Avestria Ventures Management LLC.
Former jobs include Chief Executive Officer & Director at Affymax, Inc. in 2002; Senior Director-Clinical Research at Genentech, Inc.; Independent Director at ISTA Pharmaceuticals, Inc. from 2006 to 2012; Executive Vice President at Tularik, Inc. from 1993 to 2004; Venture Partner at Presidio Partners; and President at Vitesse Biologics LLC.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from New York University.